Improvement in the mechanical efficiency of walking: An explanation for the “placebo effect” seen during repeated exercise testing of patients with heart failure
- 31 January 1998
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 135 (1), 107-114
- https://doi.org/10.1016/s0002-8703(98)70350-3
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Effects of fosinopril on exercise tolerance and clinical deterioration in patients with chronic congestive heart failure not taking digitalisThe American Journal of Cardiology, 1995
- Absence of effect on exercise capacity of 12-weeks treatment with ramipril in patients with moderate congestive heart failureEuropean Heart Journal, 1994
- Optimizing the exercise test for pharmacological investigations.Circulation, 1990
- Exercise testing in angina pectoris: The importance of protocol design in clinical trialsAmerican Heart Journal, 1989
- How should we judge the efficacy of drug therapy in patients with chronic congestive heart failure? The insights of six blind menJournal of the American College of Cardiology, 1987
- Effect of encouragement on walking test performance.Thorax, 1984
- A placebo-controlled trial of captopril in refractory chronic congestive heart failureJournal of the American College of Cardiology, 1983
- Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.Circulation, 1983
- Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failureAmerican Heart Journal, 1982
- Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failureAmerican Heart Journal, 1981